Ami in new deal with Fermion
Ami Organics, an Indian maker of pharmaceutical intermediates, API and speciality chemicals, has signed a multi-year, multi-tonne agreement with Orion subsidiary Fermion. Under this, it will supply another intermediate in addition to the one agreed in November 2022.
Financial details were not disclosed but Ami said that, based on supply projections by Fermion, “the total minimum contract value is expected to be multi-million dollar” across multiple years. The product is expected to start contributing "meaningfully" to revenue from the 2025 financial year.